The Optimal Laser Fiber Core Size for Endourological Performance

IBRAHIM M1, TOZSIN A1, RASSWEILER M2, SOYTURK S3, KALLIDONIS P4, KNOLL T5, GUVEN S3, AHMED K6

Research Type

Clinical

Abstract Category

Urolithiasis

Abstract 663
Open Discussion ePosters
Scientific Open Discussion Session 108
Saturday 20th September 2025
12:40 - 12:45 (ePoster Station 2)
Exhibition
Surgery Retrospective Study Benign Prostatic Hyperplasia (BPH)
1. Department of Urology, Trakya University School of Medicine, Edirne, Turkey, 2. Department of Urology, University Medical Centre Mannheim, Mannheim, Germany, 3. Department of Urology, Meram School of Medicine, Necmettin Erbakan University, Konya, Turkey., 4. Department of Urology, University of Patras, Patras, Greece, 5. Klinikum Sindelfingen-Boeblingen, University Medicine Mannheim, Germany, 6. Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates; Khalifa University, Abu Dhabi, United Arab Emirates ; MRC Centre for Transplantation, King’s College London, Urology, London, United Kingdom
Presenter
Links

Abstract

Hypothesis / aims of study
Laser technology advancements have been a cornerstone in urology, with the introduction of smaller core size fibers and newer lasers like thulium fiber lasers. Laser fiber core size plays an important role in the outcome of endourological procedures. This systematic review evaluates the impact of laser fiber core size on energy delivery, fiber tip degradation, thermal safety, durability, fracture resistance, retropulsion, and flexibility in endourological procedures
Study design, materials and methods
A comprehensive literature search was conducted using PubMed and Cochrane databases to identify articles that compared laser fiber core sizes. The initial search produced 1,148 articles, which were screened for relevance. After screening, 109 duplicates were removed, and 996 articles were excluded based on title and abstract screening. After the exclusion of two irretrievable articles, 43 articles underwent full-text review. Thirty articles that lacked relevant parameters or were review articles were removed. One article was added manually, and a total of 14 studies were included for review.
Results
Smaller core fibers (≤300 μm) provide higher energy delivery and greater flexibility but are prone to tip degradation and exhibit lower durability under high-power settings. Larger core fibers (≥300 μm) demonstrate superior energy efficiency, reduced tip degradation, and enhanced fracture resistance. Thermal safety is linked closely to irrigation and fiber size. Smaller fibers maintain safer temperatures under irrigation. Retropulsion is less pronounced in smaller and larger fibers compared to medium-core fibers (365–550 μm). Bubble formation during Thulium fiber laser (TFL) procedures is affected by fiber core size. Smaller fibers (150 μm) produce larger bubbles than Larger fibers (272 μm). TFL showed better flexibility, lower fracture rates, and reduced retropulsion compared to holmium: yttrium-aluminum-garnet (Ho: YAG) lasers.
Interpretation of results
Laser fiber core size has a significant influence on energy delivery, durability, thermal safety, flexibility, and retropulsion, all of which influence surgical outcomes. Smaller fibers (≤300 μm) demonstrated superior energy transmission and flexibility, making them ideal for lithotripsy. Larger fibers (≥300 μm) showed greater energy efficiency, durability, and reduced tip degradation, favouring high-power applications such as laser enucleation of the prostate. Larger fibers require proper irrigation for thermal safety. TFL showed better flexibility, lower fracture rates, and reduced retropulsion compared to holmium: yttrium-aluminum-garnet
Concluding message
Selecting the appropriate fiber size for each specific procedure is essential to optimizing surgical efficiency and improving patient outcomes.
Figure 1 The chart compares small fibers (blue) with high energy and flexibility but lower durability, to large fibers (orange) with lower energy but greater durability and reduced degradation.
Disclosures
Funding NONE Clinical Trial No Subjects None
15/07/2025 19:30:04